| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 68.8 | 77.0 | 65.3 |
| Other income | 0.6 | 1.7 | 1.0 |
| Total income | 69.4 | 78.7 | 66.3 |
| Profit before exceptional items & tax | 4.5 | 7.6 | 4.9 |
| Profit before tax | 4.5 | 7.6 | 4.9 |
| Net profit | 3.3 | 5.5 | 3.5 |
| Operating margin | 6.5% | 9.7% | 7.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -5.70% |
|---|---|
| Net profit, quarter on quarter | -40.00% |
| Revenue, year on year | +5.40% |
| Operating profit, quarter on quarter | -33.90% |
BSE results filing, NSE: AMANTA. Figures extracted from the filing.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹186.00
- Market cap
- ₹722.2 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 49.2×Sector 50.4×
- Promoter holding
- 63.80%+0.08% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amanta Healthcare Ltd
All →Amanta Healthcare Management Change
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
Amanta Healthcare Annual General Meeting
Amanta Healthcare held its 31st Annual General Meeting on September 16, 2026, transacting ordinary and special business items via video conferencing.
Amanta Healthcare Production Started
Amanta Healthcare has commenced production at its new SteriPort facility at the Kheda campus. This brownfield expansion aims to improve operational efficiency and EBITDA margins.
Amanta Healthcare Earnings Call Transcript: Key Takeaways
Amanta Healthcare delivers solid FY26 results with significant profit growth, transitioning toward high-margin specialized products like Steriport and ophthalmic solutions.
Amanta Healthcare Investor Presentation: Key Takeaways
Amanta reported Q1FY27 revenue of INR 69 Cr (5% YoY) with 21% EBITDA margins. Strategy focuses on high-margin SteriPort/SVP capacity expansion and cost optimization via solar power.
- Call
- Guides 20% growth
Amanta Healthcare Earnings Call: Key Takeaways
Amanta reported FY26 revenue of ₹288cr with 22% EBITDA margins. Strategy focuses on high-margin SteriPort capacity expansion and renewable energy cost savings.